All currency values in $ millions unless otherwise noted
Scroll
| Income Statement | DEC 2025 | DEC 2024 | DEC 2023 | DEC 2022 | DEC 2021 |
|---|---|---|---|---|---|
| Revenues | |||||
| Revenue | $370 | $395 | $492 | $454 | $358 |
| Cost of Revenue | $80 | $78 | $81 | $73 | $54 |
| Gross Profit | $291 | $317 | $411 | $381 | $304 |
| Operating Expenses | |||||
| Selling & Marketing | $181 | $181 | $193 | $161 | $119 |
| General & Administrative | $12 | $10 | $9 | $10 | $8 |
| Research & Development | $13 | $13 | $13 | $12 | $10 |
| Provision for Doubtful Accounts | $0 | $1 | $1 | $0 | $1 |
| Total Operating Expenses | $206 | $205 | $216 | $183 | $136 |
| Operating Income | $85 | $113 | $196 | $198 | $167 |
| Non-Operating | |||||
| Net Interest Expense | $25 | $31 | $22 | $4 | $1 |
| Other Non-Operating Income (Expense) | $0 | $0 | $0 | $0 | $0 |
| EBT (Earnings Before Tax) | $110 | $143 | $217 | $201 | $168 |
| Income Tax Expense | $16 | -$38 | $19 | $40 | $3 |
| Minority Interest | – | – | $0 | $0 | $0 |
| Net Income | |||||
| Net Income | $94 | $181 | $198 | $162 | $165 |
| Per Share Data | |||||
| Revenue Per Share | $5.66 | $4.90 | $5.72 | $5.32 | $4.16 |
| EPS (Basic) | $1.45 | $2.29 | $2.37 | $1.96 | $2.03 |
| EPS (Diluted) | $1.43 | $2.25 | $2.30 | $1.89 | $1.92 |
| Weighted Avg Shares (Basic) | 64.6M | 79.3M | 83.5M | 82.5M | 81.4M |
| Weighted Avg Shares (Diluted) | 65.4M | 80.6M | 86.0M | 85.4M | 86.0M |
| Shares Outstanding | 65.4M | 80.6M | 86.0M | 85.4M | 86.0M |
InMode (INMD) financials: revenue, profit and margins
InMode (INMD) generated about $370 million in revenue and $94 million in net income (a 25.3% net margin) over the trailing twelve months, growing at roughly 12.4% a year. Figures are from SEC filings; this is analysis, not investment advice.
Frequently asked
What is InMode's (INMD) revenue?+
InMode generated about $370 million in revenue over the trailing twelve months. Revenue has grown at roughly 12.4% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.
Is InMode profitable?+
Yes, InMode reported about $94 million in net income over the trailing twelve months, a net profit margin of roughly 25.3%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.
What are InMode's profit margins?+
InMode runs a gross margin of about 78.5%, an operating margin of about 23.0%, a net margin of about 25.3%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.
How fast is InMode growing?+
InMode's revenue has compounded at roughly 12.4% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside INMD's margins and free cash flow. This is analysis from SEC filings, not investment advice.
SourceFinancial statements computed from the 10-K filed 10 Feb 2026, covering the period ending 31 Dec 2025, as reported to the SEC. Data last refreshed 6 Jun 2026. How this is calculated.
Fiscal year ends Dec.
Peers
Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with INMD
Held by ETFs
INMD is in 15 US ETFs. The largest of them, with INMD's weight in each:
Avantis International Small Cap Value ETFAVDV0.01%of the fund
Schwab Fundamental International Small Equity ETFFNDC0.04%of the fund
iShares MSCI Israel ETFEIS0.16%of the fund
SPDR S&P International Small Cap ETFGWX0.10%of the fund
- SESEI Select Small Cap ETFSEIS0.19%of the fund
- VIVident International Equity Strategy ETFVIDI0.08%of the fund
Spot a number that looks wrong? Check it in INMD's SEC filings or
Download this analysis as a PDF (Pro)
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing INMD
Create a free account and get 14 days of Premium: every stock and every tool.
- Unlimited stocks
- Stock screener
- Portfolio tracker
- Editable DCF
- Compare side by side
- Unlimited alerts
No card. Moves to Free after, unless you upgrade.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.